PMID- 15331433 OWN - NLM STAT- MEDLINE DCOM- 20050531 LR - 20130520 IS - 1524-4636 (Electronic) IS - 1079-5642 (Linking) VI - 24 IP - 11 DP - 2004 Nov TI - Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. PG - e174-8 AB - Angiotensin II (Ang II) is implicated in atherogenesis by activating inflammatory responses in arterial wall cells. Ang II accelerates the atherosclerotic process in hyperlipidemic apoE-/- mice by recruiting and activating monocytes. Monocyte chemoattractant protein-1 (MCP-1) controls monocyte-mediated inflammation through its receptor, CCR2. The roles of leukocyte-derived CCR2 in the Ang II-induced acceleration of the atherosclerotic process, however, are not known. We hypothesized that deficiency of leukocyte-derived CCR2 suppresses Ang II-induced atherosclerosis. METHODS AND RESULTS: A bone marrow transplantation technique (BMT) was used to develop apoE-/- mice with and without deficiency of CCR2 in leukocytes (BMT-apoE-/-CCR2+/+ and BMT-apoE-/-CCR2-/- mice). Compared with BMT-apoE-/-CCR2+/+ mice, Ang II-induced increases in atherosclerosis plaque size and abdominal aortic aneurysm formation were suppressed in BMT-apoE-/-CCR2-/- mice. This suppression was associated with a marked decrease in monocyte-mediated inflammation and inflammatory cytokine expression. CONCLUSIONS: Leukocyte-derived CCR2 is critical in Ang II-induced atherosclerosis and abdominal aneurysm formation. The present data suggest that vascular inflammation mediated by CCR2 in leukocytes is a reasonable target of therapy for treatment of atherosclerosis. FAU - Ishibashi, Minako AU - Ishibashi M AD - Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. FAU - Egashira, Kensuke AU - Egashira K FAU - Zhao, Qingwei AU - Zhao Q FAU - Hiasa, Ken-ichi AU - Hiasa K FAU - Ohtani, Kisho AU - Ohtani K FAU - Ihara, Yoshiko AU - Ihara Y FAU - Charo, Israel F AU - Charo IF FAU - Kura, Shinobu AU - Kura S FAU - Tsuzuki, Teruhisa AU - Tsuzuki T FAU - Takeshita, Akira AU - Takeshita A FAU - Sunagawa, Kenji AU - Sunagawa K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20040826 PL - United States TA - Arterioscler Thromb Vasc Biol JT - Arteriosclerosis, thrombosis, and vascular biology JID - 9505803 RN - 0 (Apolipoproteins E) RN - 0 (Ccr2 protein, mouse) RN - 0 (Receptors, CCR2) RN - 0 (Receptors, Chemokine) RN - 11128-99-7 (Angiotensin II) SB - IM MH - Angiotensin II/*metabolism MH - Animals MH - Aortic Aneurysm, Abdominal/*etiology MH - Apolipoproteins E/deficiency MH - Arteriosclerosis/*pathology MH - Bone Marrow/*chemistry MH - Bone Marrow Transplantation/methods MH - Leukocytes/chemistry/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Inbred Strains MH - Monocytes/chemistry/metabolism MH - Receptors, CCR2 MH - Receptors, Chemokine/deficiency/*physiology EDAT- 2004/08/28 05:00 MHDA- 2005/06/01 09:00 CRDT- 2004/08/28 05:00 PHST- 2004/08/28 05:00 [pubmed] PHST- 2005/06/01 09:00 [medline] PHST- 2004/08/28 05:00 [entrez] AID - 01.ATV.0000143384.69170.2d [pii] AID - 10.1161/01.ATV.0000143384.69170.2d [doi] PST - ppublish SO - Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):e174-8. doi: 10.1161/01.ATV.0000143384.69170.2d. Epub 2004 Aug 26.